Intravenous Autologous CD19 CAR-T Cells for R/R B-ALL
Intravenous Autologous CD19 CAR-T Cells for R/R B-ALL
Recruiting · NCT03937544 · Registry updated 2025-05-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Intravenous Autologous CD19 CAR-T Cells for R/R B-ALL | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 2 / Phase 3 | 2025-05-29 | NCT03937544 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Gaia Science | 1 |
| National University of Malaysia | 43 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| UKM Medical Centre | Bandar Tun Razak | Malaysia | 1 |